# FDA Inspection 1180181 - Lilly France S.A.S. - January 15, 2021

Source: https://www.globalkeysolutions.net/records/fda_inspections/lilly-france-sas/30e61223-3f9f-4ea6-8204-f441c1a1c9df
Source feed: FDA_Inspections

> FDA Inspection 1180181 for Lilly France S.A.S. on January 15, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1180181
- Company Name: Lilly France S.A.S.
- Inspection Date: 2021-01-15
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1299456 - 2023-09-29](https://www.globalkeysolutions.net/records/fda_inspections/lilly-france-sas/64b4d0a9-9cf7-498e-b6ad-afb7780e9bdb)
- [FDA Inspection 1117961 - 2020-01-16](https://www.globalkeysolutions.net/records/fda_inspections/lilly-france-sas/2ee933c7-4e4d-450d-88fb-b9a57e20a787)
- [FDA Inspection 1117961 - 2020-01-16](https://www.globalkeysolutions.net/records/fda_inspections/lilly-france-sas/d99f9adc-7714-4e54-8f7f-504560b3191a)
- [FDA Inspection 1020863 - 2017-04-04](https://www.globalkeysolutions.net/records/fda_inspections/lilly-france-sas/e5ccc457-4508-4a84-a212-24a4fa072cb5)
- [FDA Inspection 973033 - 2016-05-03](https://www.globalkeysolutions.net/records/fda_inspections/lilly-france-sas/6064241c-18ae-4b6a-a579-1bc55f781840)

Company: https://www.globalkeysolutions.net/companies/lilly-france-sas/27fa7368-5fb0-48b1-b161-5729c7bfa061

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c